Vontobel Holding’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$105K Buy
+1,500
New +$77.6K ﹤0.01% 1408
2026
Q1
Sell
-1,500
Closed -$44.2K 1382
2025
Q4
$44.2K Hold
1,500
﹤0.01% 1410
2025
Q3
$38.7K Buy
1,500
+300
+25% +$8.37K ﹤0.01% 1334
2025
Q2
$33.1K Buy
+1,200
New +$31.6K ﹤0.01% 1249

Other funds holding MRNA

Vontobel Holding's MRNA Position: Q2 2026 in Review

Vontobel Holding reduced its Moderna (MRNA) stake by 46% in Q2 2026, selling an estimated $3.93M and leaving 87,541 shares worth $6.13M. The position accounts for 0.02% of the portfolio, ranked #408.

Vontobel Holding first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $48.9M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vontobel Holding held 87,541 shares of Moderna worth $6.13M as of Q2 2026.
  • Vontobel Holding sold 75,881 Moderna shares in Q2 2026, an estimated $3.93M.
  • Moderna made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #408 holding.
  • Vontobel Holding first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Moderna position peaked at $48.9M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.